Logo
x

Search

Subscribe Now

Orion

Orion and Aitia Join Forces for AI-Based Drug Discovery and Drug Simulation in Oncology

Orion and Aitia Join Forces for AI-Based Drug Discovery and Drug Simulation in Oncology

  • September 26, 2024
Insights+: EMA Marketing Authorization of New Drugs in March 2023

Insights+: EMA Marketing Authorization of New Drugs in March 2023

  • April 28, 2023
Orion’s Darolutamide Receives EC’s Marketing Authorisation for the Treatment of Prostate Cancer

Orion’s Darolutamide Receives EC’s Marketing Authorisation for the Treatment of Prostate Cancer

  • March 1, 2023
Orion Entered into a Research Collaboration with Peptilogics to Enable AI-Driven Drug Discovery Against Undrugged GPCR Target

Orion Entered into a Research Collaboration with Peptilogics to Enable AI-Driven Drug Discovery Against Undrugged GPCR Target

  • July 13, 2022
PharmaShots Weekly Snapshots (May 02-06, 2022)

PharmaShots Weekly Snapshots (May 02-06, 2022)

  • May 6, 2022
Orion Entered into an Agreement with Jemincare to Develop & Commercialize JMKX000623 for the Treatment of Pain

Orion Entered into an Agreement with Jemincare to Develop & Commercialize JMKX000623 for the Treatment of Pain

  • May 6, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.